SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

SNOA stock results show that Sonoma Pharmaceuticals missed on revenue for the fourth quarter of 2024.

The post SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024 appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”